Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory.

Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory.

Item
http://www.wikidata.org/entity/Q43129396
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection.Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastomaReading the tea leaves of tumor-mediated immunosuppression.Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma.The graft-versus-neuroblastoma effect of allogeneic hematopoietic stem cell transplantation, a review of clinical and experimental evidence and a perspective on mechanisms.Recipient leukocyte infusion enhances the local and systemic graft-versus-neuroblastoma effect of allogeneic bone marrow transplantation in mice.Depletion of CD25⁺ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma.IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.An optimized peptide vaccine strategy capable of inducing multivalent CD8(+) T cell responses with potent antitumor effects.Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation.Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival.Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity.Immuno-Oncology: Emerging Targets and Combination Therapies
P2860

Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory.

Item
http://www.wikidata.org/entity/Q43129396
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Depletion of CD4 T cells enhan ...... nt of antitumor immune memory.
@en
Depletion of CD4 T cells enhan ...... nt of antitumor immune memory.
@nl
type
label
Depletion of CD4 T cells enhan ...... nt of antitumor immune memory.
@en
Depletion of CD4 T cells enhan ...... nt of antitumor immune memory.
@nl
prefLabel
Depletion of CD4 T cells enhan ...... nt of antitumor immune memory.
@en
Depletion of CD4 T cells enhan ...... nt of antitumor immune memory.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Depletion of CD4 T cells enhan ...... nt of antitumor immune memory.
@en
P2093
P2860
P304
P31
P356
10.1182/BLOOD-2008-11-190827
P407
P433
P478
P577
P5875
P698
P921
P932